| |
Clinical Trials
The Lynn Institute of the Rockies is an emerging leader bringing new drugs to the market with its clinical trials program. The Lynn Institute has extensive experience in a number of areas: chronic digestive diseases such as heartburn, ulcers and irritable bowel syndrome; cardiovascular diseases and hypertension; disorders such as asthma, lung infections and cystic fibrosis; women's health; urology; rheumatoid and osteoarthritis; sleep disorders such as apnea, insomnia and narcolepsy. The Lynn Institute has conducted studies of numerous prescription drugs and over-the-counter medications. At any point in time, the Institute may be involved in as many as 50 clinical trials or more.
The Lynn Institute of the Rockies has a large patient volunteer database. This facilitates the quick start-up, enrollment and matching of patients for studies so trials can get started and completed sooner. The Lynn Institute has 8 Clinical Research Coordinators on staff.
The Lynn Institute of the Rockies focuses on Phase II, III and IV studies in the following areas:
Sleep Disorders
- Insomnia
- Narcolepsy
- Restless Legs
- Sleep Apnea
Gastrointestinal
- Ulcerative Colitis
- IBS
- GERD
- Chronic Constipation
- Crohn’s Disease
- Dyspepsia
- Erosive Esophagitis
CNS
- Generalized Anxiety Disorder
- Depression
- Anxiety
- ADHD
- Phobia
- Alzheimer
- Schizophrenia
- Bi-Polar
Arthritis
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Osteoarthritis
- Fibromyalgia
Women’s Health
- Osteoporosis
- Endometriosis
- Urinary Tract Infection
- Genital Herpes
- Menopause
- Mastalgia
- Birth Control
- Incontinence
- HPV
- Hormone Replacement
- Overactive Bladder
- Menorrhagia
Dermatology
Other
- Smoking Cessation
- Pediatrics
- Tinea Pedis
- Hypertension
- Obesity
- Vaccination
- Herpes Zoster
|